Falciparum malaria mortality in sub-Saharan Africa in the pretreatment era

James A Watson1, Nicholas J White1, Arjen M Dondorp1

  • 1Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Trends in Parasitology
|December 4, 2021
PubMed

Insights

Sickle-cell trait protects against malaria, leading to high hemoglobin S allele frequencies in Africa. This genetic balance suggests significant childhood mortality from malaria before modern treatments.

Area of Science:

  • Genetics
  • Epidemiology
  • Tropical Medicine

Background:

  • Sickle-cell trait offers protection against malaria, a significant health burden in sub-Saharan Africa.
  • Balancing selection maintains high frequencies of the sickle-cell allele (hemoglobin S) in malaria-endemic regions.

Purpose of the Study:

  • To estimate the historical burden of malaria-attributable childhood mortality in sub-Saharan Africa.
  • To understand the impact of sickle-cell trait on population genetics and disease mortality.

Main Methods:

  • Utilized population genetic data on hemoglobin S allele frequencies.
  • Employed epidemiological modeling to infer mortality rates based on allele frequencies and known protective effects.

Main Results:

  • Hemoglobin S allele frequencies range from 15% to 20% in high Plasmodium falciparum transmission areas.
  • Estimated childhood mortality attributable to malaria in the pre-treatment era was between 15% and 24%.

Conclusions:

  • The prevalence of sickle-cell trait is a direct indicator of historical malaria's severe impact on child survival.
  • Understanding this genetic-mortality relationship is crucial for public health strategies in malaria-endemic regions.

Related Concept Videos

Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...